TY - JOUR
T1 - Development of a non-viral platform for rapid virus-like particle production in Sf9 cells
AU - Puente-Massaguer, Eduard
AU - Gòdia, Francesc
AU - Lecina, Martí
N1 - Funding Information:
The authors would like to thank Dr. Paula Alves (Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal) and Dr. Julià Blanco (IrsiCaixa, Badalona, Spain) for providing the pITV5 and pGag-eGFP plasmids, respectively. We also thank Jorge Fomaro and Ángel Calvache (Beckman Coulter) for facilitating the access to the CytoFlex LX flow cytometer. The help of Núria Barba in confocal microscopy and Martí de Cabo with the cryo-TEM (Servei de Microscòpia, UAB) are also acknowledged. The support of José Amable Bernabé (Institut de Ciència de Materials de Barcelona, CSIC), Manuela Costa (Servei de Cultius Cel·lulars, Producció d'Anticossos i Citometria, UAB), Sahar Masoumeh Ghorbanpour (University of Natural Resources and Life Sciences, Vienna, Austria) and Llorenç Badiella (Servei d'Estadística Aplicada, UAB) with NTA, flow cytometry, ELISA quantification and DoE, respectively, is appreciated. Eduard Puente-Massaguer is a recipient of an FPU grant from Ministerio de Educación, Cultura y Deporte of Spain (FPU15/03577). The research group is recognized as 2017 SGR 898 by Generalitat de Catalunya.
Funding Information:
The authors would like to thank Dr. Paula Alves (Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal) and Dr. Julià Blanco (IrsiCaixa, Badalona, Spain) for providing the pITV5 and pGag-eGFP plasmids, respectively. We also thank Jorge Fomaro and Ángel Calvache (Beckman Coulter) for facilitating the access to the CytoFlex LX flow cytometer. The help of Núria Barba in confocal microscopy and Martí de Cabo with the cryo-TEM (Servei de Microscòpia, UAB) are also acknowledged. The support of José Amable Bernabé (Institut de Ciència de Materials de Barcelona, CSIC), Manuela Costa (Servei de Cultius Cel·lulars, Producció d’Anticossos i Citometria, UAB), Sahar Masoumeh Ghorbanpour (University of Natural Resources and Life Sciences, Vienna, Austria) and Llorenç Badiella (Servei d’Estadística Aplicada, UAB) with NTA, flow cytometry, ELISA quantification and DoE, respectively, is appreciated. Eduard Puente-Massaguer is a recipient of an FPU grant from Ministerio de Educación, Cultura y Deporte of Spain ( FPU15/03577 ). The research group is recognized as 2017 SGR 898 by Generalitat de Catalunya.
Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/10/10
Y1 - 2020/10/10
N2 - Insect cells have shown a high versatility to produce multiple recombinant products. The ease of culture, low contamination risk with human pathogens and high expression capacity makes an attractive platform to generate virus-like particles (VLPs). The baculovirus expression vector system (BEVS) has been frequently used to produce these complex nanoparticles. However, the BEVS entails several difficulties in the downstream phase as well as undesirable side-effects due to the expression of baculovirus-derived proteins. In this work, we developed a baculovirus-free system based on polyethylenimine (PEI)-mediated transient gene expression (TGE) of Sf9 cells. An exhaustive study of DNA:PEI polyplex formation was performed and the optimal TGE conditions were determined by the combination of Design of Experiments (DoE) and desirability functions. The TGE approach was successfully applied to produce three model recombinant products with different structural complexities, including eGFP, hSEAP and HIV-1 Gag VLPs. Cell membrane co-localization with the Gag polyprotein was detected by fluorescence microscopy, whereas nanoparticle tracking analysis and flow virometry were applied as high-throughput techniques to monitor the VLP production process. Analysis of VLP production revealed that 48 h after transfection were optimal for VLP harvesting since the ratio of VLPs to extracellular vesicles was the highest. In these conditions, a maximum of 1.9 ± 0.8·109 VLP/mL was achieved, representing a 2.8-fold increase compared to the initial transfection condition. In conclusion, the TGE approach proposed in this study provides a baculovirus-free platform to rapidly produce VLPs and potentially other recombinant products in insect cells.
AB - Insect cells have shown a high versatility to produce multiple recombinant products. The ease of culture, low contamination risk with human pathogens and high expression capacity makes an attractive platform to generate virus-like particles (VLPs). The baculovirus expression vector system (BEVS) has been frequently used to produce these complex nanoparticles. However, the BEVS entails several difficulties in the downstream phase as well as undesirable side-effects due to the expression of baculovirus-derived proteins. In this work, we developed a baculovirus-free system based on polyethylenimine (PEI)-mediated transient gene expression (TGE) of Sf9 cells. An exhaustive study of DNA:PEI polyplex formation was performed and the optimal TGE conditions were determined by the combination of Design of Experiments (DoE) and desirability functions. The TGE approach was successfully applied to produce three model recombinant products with different structural complexities, including eGFP, hSEAP and HIV-1 Gag VLPs. Cell membrane co-localization with the Gag polyprotein was detected by fluorescence microscopy, whereas nanoparticle tracking analysis and flow virometry were applied as high-throughput techniques to monitor the VLP production process. Analysis of VLP production revealed that 48 h after transfection were optimal for VLP harvesting since the ratio of VLPs to extracellular vesicles was the highest. In these conditions, a maximum of 1.9 ± 0.8·109 VLP/mL was achieved, representing a 2.8-fold increase compared to the initial transfection condition. In conclusion, the TGE approach proposed in this study provides a baculovirus-free platform to rapidly produce VLPs and potentially other recombinant products in insect cells.
KW - Cryo-transmission electron microscopy
KW - Flow virometry
KW - Polyethylenimine
KW - Sf9 cells
KW - Transient gene expression
KW - Virus-like particle
UR - http://www.scopus.com/inward/record.url?scp=85088027335&partnerID=8YFLogxK
U2 - 10.1016/j.jbiotec.2020.07.009
DO - 10.1016/j.jbiotec.2020.07.009
M3 - Article
C2 - 32673687
AN - SCOPUS:85088027335
SN - 0168-1656
VL - 322
SP - 43
EP - 53
JO - Journal of Biotechnology
JF - Journal of Biotechnology
ER -